Feature Channels: Digestive Disorders

Filters close
Released: 1-Mar-2023 9:30 AM EST
Mount Sinai Experts Urge Colon Cancer Awareness and Education to Reverse Decline in Screening Rates during Pandemic
Mount Sinai Health System

Colorectal cancer is the second leading cause of cancer deaths in both men and women in the United States. Although highly treatable and preventable, about 140,000 Americans are diagnosed and more than 50,000 people die each year, according to the Centers for Disease Control and Prevention (CDC). The United States Preventative Task Force recommends starting age of screening from 50 to 45.

Released: 1-Mar-2023 9:00 AM EST
GIQuIC Registry Announces New Partnership with Health Catalyst
American College of Gastroenterology (ACG)

The GI Quality Improvement Consortium, Inc. a national gastroenterology-focused clinical registry jointly sponsored by the American College of Gastroenterology and American Society of Gastrointestinal Endoscopy will be moving to a powerful new technology platform powered by Health Catalyst, Inc.

Newswise: New Anti-Cancer Compound Originally Discovered at Stony Brook Takes a Major Step Towards Clinical Development
Released: 28-Feb-2023 4:10 PM EST
New Anti-Cancer Compound Originally Discovered at Stony Brook Takes a Major Step Towards Clinical Development
Stony Brook University

For the past few decades, Dr. Iwao Ojima has been working in his Stony Brook University Department of Chemistry Laboratory to develop next-generation anti-cancer agents. One of these agents – a second-generation taxane conjugate (called NE-DHA-SBT-1214) – has shown great promise against solid tumors – particularly against colorectal cancer.

Newswise: Increase in Colorectal Cancer Among Younger Individuals Continues to Rise
Released: 28-Feb-2023 1:40 PM EST
Increase in Colorectal Cancer Among Younger Individuals Continues to Rise
Rutgers Cancer Institute of New Jersey

Expert from Rutgers Cancer Institute of New Jersey & RWJBarnabas Health discusses what young people should know about colorectal cancer as the disease continues to rise in those ranging in age from mid-20's to 50's.

Newswise: Your Gut’s Microbiome, On a Chip
24-Feb-2023 10:05 AM EST
Your Gut’s Microbiome, On a Chip
American Institute of Physics (AIP)

In APL Bioengineering, researchers describe how gut-on-a-chip devices can bridge lab models and human biology. Modeling the microbiome is particularly difficult because of its unique environmental conditions, but through creative design, gut-on-a-chip devices can simulate many of these properties, such as the gut’s anaerobic atmosphere, fluid flow, and pulses of contraction/relaxation. Growing intestinal cells in this environment means that they more closely resemble human biology compared to standard laboratory cell cultures.

   
Released: 28-Feb-2023 10:05 AM EST
Mayo Clinic Healthcare expert: Artificial intelligence improves colonoscopy accuracy
Mayo Clinic

James East, M.D., spends his days skillfully examining people’s colons, searching for and snaring away suspicious polyps that might one day turn into cancer. A gastroenterologist at Mayo Clinic Healthcare in London, he says the ability to identify cancer risks and eliminate them on the spot during a colonoscopy is one of the most satisfying parts of his chosen profession.

Released: 28-Feb-2023 8:05 AM EST
How to Improve Your Gut Health with Plant-Based Foods
Monday Campaigns

For March, National Nutrition Month, an annual campaign by the Academy of Nutrition and Dietetics, the Meatless Monday team is sharing tips and insights on how to improve gut health with plant-based foods.

Released: 28-Feb-2023 7:00 AM EST
خبير من مايو كلينك للرعاية الصحية: الذكاء الاصطناعي يحسن دقة تنظير القولون
Mayo Clinic

لندن - يقضي جيمس إيست، دكتور الطب، أيامه في فحص قولون الناس بمهارة، والبحث عن السلائل المشبوهة التي قد تتحول يومًا ما إلى سرطان، والتخلص منها. يقول طبيب الجهاز الهضمي في مايو كلينك للرعاية الصحية في لندن، إن القدرة على التعرف على مخاطر الإصابة بالسرطان والقضاء عليها في الحال خلال تنظير القولون من الأمور المجزية للغاية في مهنته التي اختارها.

Newswise: The Molecular Mechanism Behind Abdominal Aneurysms
Released: 23-Feb-2023 10:05 AM EST
The Molecular Mechanism Behind Abdominal Aneurysms
University of Maryland School of Medicine

In a new study using mice, University of Maryland School of Medicine researchers were able to tease apart the molecular components involved in abdominal aneurysms to better understand how and why they form.

17-Feb-2023 12:55 PM EST
Study: People Who Regularly Use Laxatives May Have an Increased Risk of Dementia
American Academy of Neurology (AAN)

People who regularly use laxatives, a common treatment for constipation, may have more than a 50% increased risk of developing dementia than people who do not use laxatives, according to a study published in the February 22, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. Researchers also found people who used only osmotic laxatives, a type of laxative that attracts water to the colon to soften stool, had an even greater risk. Other types of laxatives are bulk-forming, stool-softening, and stimulating. The study does not prove that laxatives cause dementia. It only shows an association.

Released: 22-Feb-2023 12:00 PM EST
MD Anderson Research Highlights for February 22, 2023
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. Recent developments include a new understanding of how HPV drives cancer development, a combination therapy to overcome treatment resistance in mantle cell lymphoma, novel insights into memory T cell formation and potential therapeutic strategies for brain cancers, improved survival outcomes for metastatic colorectal cancer, targeting myeloperoxidase to improve immunotherapy responses in melanoma, and preclinical results of a combination therapy that could effectively treat a subset of acute myeloid leukemia.

   

Not for public release

This news release is embargoed until 20-Feb-2023 5:00 PM EST Released to reporters: 14-Feb-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 20-Feb-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 20-Feb-2023 5:00 PM EST Released to reporters: 14-Feb-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 20-Feb-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 20-Feb-2023 8:05 AM EST
Improving Disease Monitoring for Hispanic Children With IBD
Children's Hospital Los Angeles

Study aims to adjust the Pediatric Ulcerative Colitis Activity Index to better reflect disease activity in Hispanic children. New research at Children’s Hospital Los Angeles is aiming to improve the accuracy of the Pediatric Ulcerative Colitis Activity Index (PUCAI) for Hispanic children. A simple questionnaire that’s widely used to monitor disease activity, the PUCAI tool has been well-studied and validated—but mainly in white populations.

Newswise: Fiber discovery could shape better gut health
Released: 16-Feb-2023 2:50 PM EST
Fiber discovery could shape better gut health
University of Nottingham

Changing the structure of a dietary fibre commonly found in a range of food products has been found to promote healthy gut bacteria and reduce gas formation, a finding that could help people with intolerances to fibre and irritable bowel conditions.

Released: 16-Feb-2023 11:05 AM EST
New Drug Target to Treat Pain from Visceral Organs
Thomas Jefferson University

An approved drug for chronic constipation also relieves the pain associated with that condition. New research demonstrates that the drug’s two actions can be separated biologically — a finding that may offer ways to precisely target visceral organ pain syndromes beyond constipation.

Released: 16-Feb-2023 7:00 AM EST
أسئلة وأجوبة مايو كلينك: كل ما يتعلق بأنواع حساسية الطعام وحالات عدم تحمله
Mayo Clinic

عزيزتي مايو كلينيك: أنا جدة لثلاثة أحفاد رائعين. حفيدي الأكبر يعاني من عدم تحمل اللاكتوز. وفي الفترة الأخيرة، تم تشخيص حفيدي الأصغر بحساسية الفول السوداني. ما الفرق بين عدم تحمل الطعام وحساسية الطعام؟ الإجابة: تختلف الحياة على مائدة العشاء لآلاف الأشخاص في الولايات المتحدة المصابين بأحد أنواع حساسية الطعام. تظهر الدراسات الحديثة أن ما يقرب من 5% من الأطفال دون سن الخامسة، و3% من البالغين يعانون من أنواع حساسية الطعام. يتراوح انتشار حساسية الطعام في جميع أنحاء العالم من 1.1% إلى 10.8%.

Released: 16-Feb-2023 7:00 AM EST
Perguntas e respostas da Mayo Clinic: Tudo sobre alergias e intolerâncias alimentares
Mayo Clinic

ESTIMADA MAYO CLINIC: Sou avó de três netos maravilhosos. Meu neto mais velho é intolerante à lactose. Recentemente, meu neto mais novo foi diagnosticado com alergia a amendoim. Qual é a diferença entre intolerância e alergia alimentar? RESPOSTA: A rotina à mesa de jantar é diferente para milhares de pessoas nos Estados Unidos que têm alguma alergia alimentar.

Released: 16-Feb-2023 6:00 AM EST
Preguntas y respuestas de Mayo Clinic: todo sobre la alergia y la intolerancia alimentaria
Mayo Clinic

Soy abuela de tres grandiosos nietos. Mi nieto mayor tiene intolerancia a la lactosa. Hace poco, a mi nieto menor le diagnosticaron alergia al cacahuate (maní). ¿Cuál es la diferencia entre la intolerancia y la alergia alimentaria?

Released: 15-Feb-2023 5:25 PM EST
UCLA receives $20 million to establish Goodman–Luskin Microbiome Center
University of California, Los Angeles (UCLA), Health Sciences

A $20 million gift from Andrea and Donald Goodman and Renee and Meyer Luskin will fund a new center at UCLA focused on the microbiome and its effect on health.

Released: 15-Feb-2023 10:20 AM EST
Food coloring nanoparticles may affect human gut
Cornell University

Metal oxide nanoparticles – commonly used as food coloring and anti-caking agents in the commercial ingredients industry – may damage parts of the human intestine, according to new research by Cornell and Binghamton University scientists.

Newswise: What’s your gut telling you?
Released: 13-Feb-2023 1:35 PM EST
What’s your gut telling you?
NYU Tandon School of Engineering

In a study published in Nature Electronics, Khalil B. Ramadi, Assistant Professor of Bioengineering at NYU Tandon School of Engineering, revealed that he and a team of collaborators at MIT and Caltech have developed a tiny pill-like electromagnetic device that, once swallowed, could provide medical professionals a diagnostic window into the inner workings of the gastrointestinal (GI) tract.

Newswise: Study Confirms Pancreatic Cancer Rates Rising Faster in Women Than Men
Released: 10-Feb-2023 12:45 PM EST
Study Confirms Pancreatic Cancer Rates Rising Faster in Women Than Men
Cedars-Sinai

In a large-scale nationwide study, investigators from Cedars-Sinai Cancer have confirmed that rates of pancreatic cancer are rising—and are rising faster among younger women, particularly Black women, than among men of the same age. Their work was published today in the peer-reviewed journal Gastroenterology.

Newswise: February Issue of AJG Features New Guideline on Acute Lower GI Bleeding
AUDIO
Released: 8-Feb-2023 9:00 AM EST
February Issue of AJG Features New Guideline on Acute Lower GI Bleeding
American College of Gastroenterology (ACG)

The February issue of The American Journal of Gastroenterology features a new ACG Clinical Guideline on Acute Lower GI Bleeding, a common reason for hospitalization in digestive diseases, which can be challenging to assess and triage.

Released: 31-Jan-2023 5:05 PM EST
The latest research news on surgery and transplants
Newswise

Below are some of the latest articles that have been added to the Surgery and the Transplantation channels on Newswise, a free source for journalists.

Released: 26-Jan-2023 9:30 AM EST
New research paper supports using microbiome data to develop potential probiotic therapies
University Hospitals Cleveland Medical Center

In the journal Gastroenterology, researchers from University Hospitals and Case Western Reserve University School of Medicine in Cleveland publish a review of studies about the microbiome's role in disease and discuss data from clinical trials involving individuals with digestive issues and Crohn's disease treated with a probiotic formulation. Results showed the formulation reduced severity and frequency of overall GI symptoms and positively modulated specific symptoms.

Newswise: $2.9M NIH Grant to Study Genetics of IBD in Hispanic Population
Released: 25-Jan-2023 4:05 PM EST
$2.9M NIH Grant to Study Genetics of IBD in Hispanic Population
University of Miami Health System, Miller School of Medicine

Researchers at the University of Miami Miller School of Medicine were awarded a $2.9 million grant by the National Institutes of Health (NIH) to spend the next five years collecting and analyzing the genetic data of more than 3,000 Hispanic individuals, to better understand IBD in that community.

Newswise: Nanofiber-Hydrogel Loaded with Stem Cells Shows Success Treating Severe Complication of Crohn’s Disease
Released: 25-Jan-2023 10:00 AM EST
Nanofiber-Hydrogel Loaded with Stem Cells Shows Success Treating Severe Complication of Crohn’s Disease
Johns Hopkins Medicine

In a new study using a rat model of Crohn’s disease, a biodegradable hydrogel composite loaded with stem cells, developed by Johns Hopkins Medicine researchers, in a collaborative effort with the Whiting School of Engineering, has shown significant success in treating perianal fistulas (PAF) — one of the many complications of Crohn’s disease.

Newswise: UC San Diego Health Gastrointestinal Endoscopy Unit Recognized Nationally
Released: 24-Jan-2023 2:10 PM EST
UC San Diego Health Gastrointestinal Endoscopy Unit Recognized Nationally
UC San Diego Health

UC San Diego Health’s gastroenterology endoscopy program has been recognized as a leader in quality and safety by the American Society for Gastrointestinal Endoscopy (ASGE), the leading national gastrointestinal endoscopy medical society.

Newswise:Video Embedded largest-study-on-long-term-follow-up-of-chronic-pancreatitis-patients-highlights-need-for-closer-monitoring-after-surgery
VIDEO
18-Jan-2023 11:00 AM EST
Largest study on long-term follow-up of chronic pancreatitis patients highlights need for closer monitoring after surgery
American College of Surgeons (ACS)

The largest study to date of patients who have had surgery for chronic pancreatitis with follow-up of six years or longer has found that about two-thirds survive after 10 years. However, more than one-fourth of these patients were still using opioids daily for pain.

Released: 20-Jan-2023 7:00 PM EST
New hope for treatment of rare metabolic disease
Universität Leipzig

X-linked adrenoleukodystrophy (X-ALD) is the most common of a group of around 50 rare diseases of the white matter of the brain, the so-called leukodystrophies.

Released: 19-Jan-2023 5:40 PM EST
Lower bacterial diversity is associated with irritable bowel syndrome
American Society for Microbiology (ASM)

People with irritable bowel syndrome (IBS) have lower bacterial diversity in the intestine than do healthy people, according to a team of Korean investigators.

Newswise: How Pancreatic Cancer Defies Treatment
Released: 19-Jan-2023 12:10 PM EST
How Pancreatic Cancer Defies Treatment
University of California San Diego

UC San Diego researchers describe how pancreatic cancer stem cells leverage a protein in a family of proteins that normally suppress tumors to instead do the opposite, boosting their resistance to conventional treatments and spurring growth.

Released: 18-Jan-2023 5:55 PM EST
Delayed appendicitis diagnosis more common among non-Hispanic Black adults
Northwestern University

Non-Hispanic Black adults more frequently experience delays in receiving an appendicitis diagnosis in hospital emergency departments, putting them at a higher likelihood of perforated appendicitis and subsequent post-surgical infections, reports a new Northwestern Medicine study.

Newswise: Salmonella exposure a risk for colon cancer
Released: 17-Jan-2023 4:45 PM EST
Salmonella exposure a risk for colon cancer
University of Illinois Chicago

Researchers studied human colon cancer tissue samples and animal models and found that exposure to salmonella was linked with colon cancers that developed earlier and grew larger.

Newswise: RUSH Introduces the Joan and Paul Rubschlager Building
Released: 13-Jan-2023 1:50 PM EST
RUSH Introduces the Joan and Paul Rubschlager Building
RUSH

On Friday, Jan 13, at 8:30 a.m., RUSH leaders and U.S. Sen. Richard Durbin officially unveiled the Joan and Paul Rubschlager Building and explained how the 10-story, $450 million outpatient facility embodies the future of health care: convenient, life-saving care delivered in an outpatient setting for cancer, neuroscience and digestive diseases patients.

12-Jan-2023 4:00 PM EST
Molecular tumor board provides useful assist in cancer precision medicine
Dana-Farber Cancer Institute

A paper posted online by JCO Precision Oncology reports that a molecular tumor board program has largely fulfilled expectations, providing expert treatment guidance for more than 500 patients over the six-month evaluation period and identifying clinical trials appropriate for the majority of them. Overall, the team has reviewed test results for more than 2,700 patients to date. The findings suggest that the program can be a model for other cancer centers.

Newswise: Realtime monitoring with a wearable device reveals IBS-related changes
Released: 12-Jan-2023 2:40 PM EST
Realtime monitoring with a wearable device reveals IBS-related changes
Osaka Metropolitan University

Irritable bowel syndrome (IBS) is a difficult disease to treat, characterized by chronic abdominal pain related to bowel movements, of which there are four types: diarrheal, constipation, mixed, and unclassifiable.

   
Released: 12-Jan-2023 10:35 AM EST
Evidence Map of Gut Metabolites Identifies Links to Cancer, Digestive Disorders
Institute for the Advancement of Food and Nutrition Sciences

Review of over 300 studies sifts out relationships between metabolites and health worth a further look.

   
Released: 12-Jan-2023 10:05 AM EST
Especialista da Mayo Clinic Healthcare explica por que a doença do refluxo não é apenas uma azia
Mayo Clinic

A doença do refluxo gastroesofágico é um dos distúrbios digestivos mais comuns do mundo. Acontece quando o ácido do estômago sobre para o esôfago: o estômago é capaz de resistir ao ácido, mas o esôfago é menos resistente. O Dr. James East, gastroenterologista da Mayo Clinic Healthcare em Londres, diz que a doença do refluxo pode ser comum, mas pode haver complicações graves se for constante e não for tratada.

Released: 12-Jan-2023 10:05 AM EST
Mayo Clinic Healthcare expert explains why reflux disease isn’t `just’ heartburn
Mayo Clinic

Gastroesophageal reflux disease is one of the most common digestive disorders in the world. It happens when acid comes up from the stomach into the esophagus: The stomach can resist acid but the esophagus is less acid-resistant. James East, M.D., a gastroenterologist at Mayo Clinic Healthcare in London, says reflux disease may be common, but there can be severe complications if it is ongoing and left untreated.

Released: 12-Jan-2023 9:00 AM EST
El experto de Mayo Clinic Healthcare explica por qué la enfermedad por reflujo no es "simplemente" acidez estomacal
Mayo Clinic

a enfermedad por reflujo gastroesofágico es uno de los trastornos digestivos más comunes en el mundo. Se produce cuando el ácido del estómago regresa hacia el esófago: el estómago puede resistir el ácido, pero el esófago no tiene tanta resistencia. El Dr. James East, gastroenterólogo de Mayo Clinic Healthcare en Londres, dice que la enfermedad por reflujo puede ser común, pero que puede presentar complicaciones graves si es persistente y no se trata.

Released: 12-Jan-2023 1:05 AM EST
خبير من مايو كلينك للرعاية الصحية يشرح لماذا داء الجَزْر ليس مجرد حرقة في المعدة
Mayo Clinic

لندن - داء الجَزْر المَعدي المريئي هو أحد أكثر اضطرابات الهضم شيوعًا حول العالم. يحدث عندما يعود الحمض من المعدة إلى المريء: يمكن للمعدة مقاومة الأحماض ولكن المريء أقل مقاومة للأحماض. جيمس إيست، دكتور الطب، طبيب الجهاز الهضمي في مايو كلينك للرعاية الصحية في لندن، يقول إن داء الجَزْر قد يكون شائعًا، ولكن قد تحدث مضاعفات إذا ظل مستمرًا وتُرِكَ دون علاج.

Released: 12-Jan-2023 12:05 AM EST
妙佑医疗中心专家解释为什么反流病不“只是”胃灼热?
Mayo Clinic

伦敦 — 胃食管反流病是世界上最常见的消化道疾病之一。当胃酸从胃部上升到食管时就会发生这种状况:胃能抗酸,但食管的抗酸能力却没有那么强。妙佑伦敦医疗中心的胃肠科医生James East(医学博士)说反流病虽然很常见,但如果长期不加以治疗,可能会出现严重的并发症。



close
1.33667